EE9700355A - Promootorid geeni ekspressiooniks - Google Patents

Promootorid geeni ekspressiooniks

Info

Publication number
EE9700355A
EE9700355A EE9700355A EE9700355A EE9700355A EE 9700355 A EE9700355 A EE 9700355A EE 9700355 A EE9700355 A EE 9700355A EE 9700355 A EE9700355 A EE 9700355A EE 9700355 A EE9700355 A EE 9700355A
Authority
EE
Estonia
Prior art keywords
promoters
gene expression
region
promoter
novel
Prior art date
Application number
EE9700355A
Other languages
English (en)
Estonian (et)
Inventor
A. Lagosky Peter
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9700355A publication Critical patent/EE9700355A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EE9700355A 1995-05-19 1996-05-16 Promootorid geeni ekspressiooniks EE9700355A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/445,133 US5629205A (en) 1995-05-19 1995-05-19 Promoters for gene expression
PCT/IB1996/000462 WO1996036721A1 (en) 1995-05-19 1996-05-16 Promoters for gene expression

Publications (1)

Publication Number Publication Date
EE9700355A true EE9700355A (et) 1998-06-15

Family

ID=23767732

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700355A EE9700355A (et) 1995-05-19 1996-05-16 Promootorid geeni ekspressiooniks

Country Status (24)

Country Link
US (1) US5629205A (es)
EP (1) EP0828844B1 (es)
JP (2) JP3828576B2 (es)
KR (1) KR19990014906A (es)
CN (1) CN1131313C (es)
AT (1) ATE248923T1 (es)
AU (1) AU698656B2 (es)
BR (1) BR9609102A (es)
CA (1) CA2221587C (es)
CZ (1) CZ357997A3 (es)
DE (1) DE69629808T2 (es)
DK (1) DK0828844T3 (es)
EE (1) EE9700355A (es)
ES (1) ES2202436T3 (es)
HU (1) HUP9900750A3 (es)
IS (1) IS4609A (es)
MX (1) MX9708689A (es)
NO (1) NO325879B1 (es)
NZ (1) NZ306536A (es)
PL (1) PL324226A1 (es)
PT (1) PT828844E (es)
SK (1) SK154997A3 (es)
TR (1) TR199701394T1 (es)
WO (1) WO1996036721A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194168B1 (en) * 1997-09-30 2001-02-27 Human Genome Sciences, Inc. Expression control sequences
AU2003243316A1 (en) * 2002-05-24 2003-12-12 Nps Allelix Corp. Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
WO2005046798A1 (en) * 2003-11-12 2005-05-26 Nps Allelix Corp. Treatment of bone loss utilizing full length parathyroid hormone
HRP20120315T1 (hr) * 2003-11-21 2012-05-31 Nps Pharmaceuticals Proizvodnja peptida 2 nalik glukagonu i analoga
US20060177895A1 (en) * 2003-12-12 2006-08-10 Chung Chan Methods for enhancing expression of recombinant proteins
ES3011307T3 (en) 2012-02-23 2025-04-07 Juno Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
EP3365453A2 (en) 2015-10-22 2018-08-29 Juno Therapeutics GmbH Methods, kits, agents and apparatuses for transduction
MX2018004875A (es) 2015-10-22 2018-08-01 Juno Therapeutics Gmbh Metodos para cultivar celulas y kits y aparatos para ello.
JP7339160B2 (ja) 2017-04-27 2023-09-05 ジュノ セラピューティクス ゲーエムベーハー オリゴマー粒子試薬およびその使用方法
CN108060168B (zh) * 2017-12-29 2021-06-29 苏州金唯智生物科技有限公司 一种改进的启动子及其组成的t载体和应用
CN108118058B (zh) 2017-12-29 2021-06-29 苏州金唯智生物科技有限公司 一种改进的启动子及其应用
CN108165551B (zh) * 2017-12-30 2021-06-29 苏州金唯智生物科技有限公司 一种改进的启动子及其组成的t载体和应用
CN108118059B (zh) 2017-12-30 2021-03-19 苏州金唯智生物科技有限公司 一种改进的启动子及其组成的载体和应用
US20220049260A1 (en) * 2018-09-11 2022-02-17 Boehringer Ingelheim Rcv Gmbh & Co. Kg Inducible expression system for plasmid-free production of a protein of interest
SG11202104355SA (en) 2018-10-31 2021-05-28 Juno Therapeutics Gmbh Methods for selection and stimulation of cells and apparatus for same
CN118995554B (zh) * 2024-09-09 2025-07-04 江南大学 一种大肠杆菌整合表达体系及其在酶高效表达中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8517071D0 (en) * 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
EP0303925B1 (de) * 1987-08-17 1995-06-07 F. Hoffmann-La Roche Ag Hochreprimierbare Expressionskontrollsequenzen
US5223407A (en) * 1988-08-31 1993-06-29 Allelix Inc. Excretion of heterologous proteins from e. coli
US5171670A (en) * 1989-05-12 1992-12-15 The General Hospital Corporation Recombinant dna method for production of parathyroid hormone
WO1992003560A1 (en) * 1990-08-28 1992-03-05 E.I. Du Pont De Nemours And Company A method for rapid selection of efficient secretion vectors

Also Published As

Publication number Publication date
CN1190993A (zh) 1998-08-19
DE69629808D1 (de) 2003-10-09
EP0828844B1 (en) 2003-09-03
KR19990014906A (ko) 1999-02-25
PT828844E (pt) 2004-01-30
HUP9900750A2 (hu) 1999-06-28
CN1131313C (zh) 2003-12-17
NO325879B1 (no) 2008-08-11
DK0828844T3 (da) 2004-01-05
AU5511696A (en) 1996-11-29
MX9708689A (es) 1998-02-28
TR199701394T1 (xx) 1998-02-21
PL324226A1 (en) 1998-05-11
IS4609A (is) 1997-11-07
ATE248923T1 (de) 2003-09-15
NO975286D0 (no) 1997-11-18
NO975286L (no) 1997-11-18
CA2221587A1 (en) 1996-11-21
JP2006187295A (ja) 2006-07-20
HK1004148A1 (en) 1998-11-20
ES2202436T3 (es) 2004-04-01
NZ306536A (en) 1999-10-28
US5629205A (en) 1997-05-13
DE69629808T2 (de) 2004-07-15
HUP9900750A3 (en) 1999-11-29
JP3837154B2 (ja) 2006-10-25
BR9609102A (pt) 1999-05-11
JP3828576B2 (ja) 2006-10-04
CZ357997A3 (cs) 1998-04-15
CA2221587C (en) 2008-07-08
SK154997A3 (en) 1998-05-06
EP0828844A1 (en) 1998-03-18
WO1996036721A1 (en) 1996-11-21
AU698656B2 (en) 1998-11-05
JPH11509083A (ja) 1999-08-17

Similar Documents

Publication Publication Date Title
EE9700355A (et) Promootorid geeni ekspressiooniks
AU8131294A (en) Human kunitz-type protease inhibitors
BR9608149A (pt) Variante de subtilase processos para efetuar a mutação no dna que codifica uma enzima de subtilase para a manufatura de uma enzima de subtilase mutante e para produzir a variante sequência de dna vetor e hospedeiro microbiano
DE69634412D1 (de) Regulierte gene und ihre verwendungen
FI971777A0 (fi) Katepsiini O2-proteaasi
DE69738873D1 (de) Mutierte penicillin g acylasen
WO1994012637A3 (en) Novel human amyloid protein precursor homologue and kunitz-type inhibitors
AU2002230691A1 (en) Putrescine-n-methyltransferase promoter
DE59912185D1 (de) Verwendung von hsp70 protein
NO974035L (no) En ny vekstfaktor og en genetisk sekvens som koder for denne
FI961666A7 (fi) Restenosiksen geeniterapia, jossa käytetään adenovirusvektoria
ATE308619T1 (de) Steigerung der genexpression
EP0737249A4 (en) THE TUMORE-REPRESSING PROTEIN PRB2, RELATED GENE PRODUCTS, AND THE ENCODING DNA
FR2744455B1 (fr) Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications
WO1998008965A3 (en) Cd95 regulatory gene sequences and transcription factors
ATE316138T1 (de) Rekombinante expression von s-layer-proteinen
FI946076A0 (fi) Modifioituja Kluyveromyces-hiivoja, valmistus ja käyttö
NO951315L (no) Ökt produksjon av utsondrede proteiner fra rekombinante eukaryote-celler
AU2002350545A1 (en) Use of the adenoviral e2 late promoter
PT870015E (pt) Novas xilanases os genes que as codificam e as suas utilizacoes
AU5239290A (en) Purification of c.pseudotuberculosis toxin, and cloning and expression of toxin gene
SE9600171D0 (sv) Användning av tidigare känt material för separation och nya former av materialet
ITMI931034A1 (it) Processo per la preparazione di proteine inibenti i ribosomi
ATE93893T1 (de) Expressionssysteme zur ueberproduktion gewuenschter proteine.